Workflow

EQS-News: TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024

Retrieved on: 
Wednesday, April 10, 2024
Radiation, Thrombosis, Partner (business rank), Infection, Intelligence, TVM, Risk, General partnership, Patient, Eye injury, Standard of care, AI, Workflow, Investment, LSI, Phlebitis, Eli Lilly and Company, Vector, Therapy, FDA, Physician, Health, PFC, Medical imaging

Munich, Germany and Montreal, Quebec, Canada (March 13, 2024) – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that the Company will participate in the sixth annual LSI USA ’24 Emerging Medtech Summit 2024, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.

Key Points: 
  • Munich, Germany and Montreal, Quebec, Canada (March 13, 2024) – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that the Company will participate in the sixth annual LSI USA ’24 Emerging Medtech Summit 2024, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.
  • The conference will take place March 18-22, 2024, in Dana Point, California, USA.
  • "Medtech innovation continues to be at the forefront of healthcare advancement, driving transformative changes in patient care, operational efficiency and cost reduction.
  • As part of our commercial-stage medical technologies investment strategy, TVM seeks breakthrough solutions that align with emerging trends and could redefine the standard of care.

EQS-News: 3U HOLDING AG given the green light for the repowering project in the Langendorf Wind Farm / Saxony-Anhalt

Retrieved on: 
Wednesday, April 10, 2024
Electricity, Wind, Primary energy, Farm, Growth, Environment, Vestas, Workflow, CO2, Kilowatt-hour, Renewable energy

Consequently, a positive decision is the most important regulatory milestone in the whole project workflow for an enterprise of this kind.

Key Points: 
  • Consequently, a positive decision is the most important regulatory milestone in the whole project workflow for an enterprise of this kind.
  • The repowering project provides for seven of the 15 existing wind turbines to be replaced by five new turbines.
  • 3U ENERGY PE GmbH is managing the project involving the entire conversion measures on the Langendorf Wind Farm.
  • The new facilities in the Langendorf Wind Farm are expected to go live and produce electricity in the fourth quarter of 2025 at the latest.

DEXIS Enhances its Dental Implant Ecosystem with Intraoral Scanning Software Update - DEXIS IS ScanFlow

Retrieved on: 
Tuesday, March 19, 2024
Diagnosis, Automation, Algorithm, Noise, Communication, Digital, AI, Software, Marketing, Workflow, History, Artifact, Data, Dentist, Medical device

To enhance workflow efficiencies, DEXIS announces the release of a new intraoral scanning update, DEXIS(TM) IS ScanFlow v.1.0.10.

Key Points: 
  • To enhance workflow efficiencies, DEXIS announces the release of a new intraoral scanning update, DEXIS(TM) IS ScanFlow v.1.0.10.
  • The update includes a new series of guided workflows, enhancements to its AI capabilities, and an integration with DEXIS Imaging Suite software version 10.
  • "We are excited to introduce our latest DEXIS intraoral scanning software update, aimed at boosting productivity for DEXIS software owners and implant workflows," says Brian Gooch, VP of Marketing at DEXIS.
  • The IS ScanFlow software update maintains high-speed scanning, user-friendly interface, precise data capture, and an open, flexible system.

Backblaze Launches Next-Gen Cloud Workflow Tools, Security Announcements, and More at NAB 2024

Retrieved on: 
Tuesday, April 9, 2024
Cloud, Media, SAN, Workflow, Search engine, Business development, AI, Backblaze, Backlight, Human back, NAB Show, Cryptocurrency

The Backblaze team will highlight announcements relating to automating cloud workflows, expanding media archive search functionality with AI, and advancing security standards within the industry while also sharing information on the company’s industry-leading cloud object storage platform.

Key Points: 
  • The Backblaze team will highlight announcements relating to automating cloud workflows, expanding media archive search functionality with AI, and advancing security standards within the industry while also sharing information on the company’s industry-leading cloud object storage platform.
  • April 14, 3:00 p.m: “Quantum Featuring AI Tools, CatDV Classic & .io Utilizing Backblaze for Primary Storage” with Leslie Hathaway, Sales Engineer and Brian Scheffler, Pre-Sales Sys.
  • April 15, 10:00 a.m.: “Cloud-Powered Remote Production: Collaborative Video Editing on the Back of Backblaze” with CuttingRoom Co-Founder Helge Høibraaten.
  • April 15, 11:00 a.m.: “Optimizing Media Workflow: Leveraging iconik and Backblaze for Cost-Effective, Searchable Storage” with Mattia Varriale, Sales Director EMEA at Backlight.

LDRA Launches Productivity Packages to Optimize Workflows for Functional Safety and Security Standards Compliance

Retrieved on: 
Monday, April 8, 2024
LDRA, Embedded, Certification, Artifact, Workflow, Documentation, Environment, Running, Transport, Medical device

WIRRAL, UK, April 08, 2024 (GLOBE NEWSWIRE) -- WIRRAL, UK—April 8, 2024— LDRA , the leader in automated software verification, traceability and standards compliance, today launched domain-specific software productivity packages for the LDRA tool suite :.

Key Points: 
  • WIRRAL, UK, April 08, 2024 (GLOBE NEWSWIRE) -- WIRRAL, UK—April 8, 2024— LDRA , the leader in automated software verification, traceability and standards compliance, today launched domain-specific software productivity packages for the LDRA tool suite :.
  • LDRA’s new productivity packages provide all the necessary software tools to demonstrate compliance with each industry’s highest required assurance levels.
  • The LDRA Productivity Packages offer capabilities ranging from static and dynamic analysis with unit and integration testing to complete compliance reporting for specific industry standards and assurance levels.
  • Functional safety and security are fundamental to each of the productivity packages and include capabilities such as coding standards compliance, security assessments, automatic test case generation, execution, artifact generation and compliance reporting.

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

Retrieved on: 
Monday, April 8, 2024
Well, Small-cell carcinoma, Therapeutic index, Glomus tumor, Endometrial cancer, Survival, Environment, Service provider, Trichloroethylene, Patient, Primate, Triple-negative breast cancer, Lead, Zymeworks, 3D, Standard of care, Cancer, TAA, Spacecraft, Lung cancer, IND, CD3, DLL3, AACR, Workflow, Antibody, TCE, CD28, Therapy, Stomach, ADC, Vaccine

The compelling preclinical activity profile supports ZW191 development across multiple tumor types, including FRα-high/mid/low ovarian cancers and other FRα-expressing indications, including non-small cell lung cancer, endometrial cancer, and triple-negative breast cancer.

Key Points: 
  • The compelling preclinical activity profile supports ZW191 development across multiple tumor types, including FRα-high/mid/low ovarian cancers and other FRα-expressing indications, including non-small cell lung cancer, endometrial cancer, and triple-negative breast cancer.
  • An investigational new drug (IND) submission or foreign equivalent is planned for 2024.
  • Small cell lung cancer (SCLC) is an aggressive neuroendocrine cancer with a poor prognosis and high unmet medical need2.
  • Displays no cross-linking of T cells and exhibits obligate cis T cell binding of CD28, requiring co-engagement of CD3.

Glycotope to present platform approach for development of anti-GlycoTarget antibodies at 2024 AACR Meeting

Retrieved on: 
Monday, April 8, 2024
Protein, Workflow, AACR, Data collection, Database, Antibody, Vaccine

Berlin, Germany, 08 April, 2024 – Glycotope GmbH, a biotechnology company utilizing a proprietary platform technology to developing antibodies against proteins carrying tumor-specific carbohydrate structures, today announces that it will present its platform approach and GlycoTarget database in a poster presentation at the 2024 American Association for Cancer Research (AACR) Meeting, being held in San Diego, California, United States, between 05-10 April 2024.

Key Points: 
  • Berlin, Germany, 08 April, 2024 – Glycotope GmbH, a biotechnology company utilizing a proprietary platform technology to developing antibodies against proteins carrying tumor-specific carbohydrate structures, today announces that it will present its platform approach and GlycoTarget database in a poster presentation at the 2024 American Association for Cancer Research (AACR) Meeting, being held in San Diego, California, United States, between 05-10 April 2024.
  • Patrik Kehler, Chief Scientific Officer of Glycotope GmbH commented: “At Glycotope, we have established a standardized process for the data collection and prioritization of potential protein/carbohydrate combined glycoepitopes (GlycoTargets).
  • We look forward to attending AACR to present our workflow and corresponding database to leading cancer research experts, illustrating how this information is subsequently used for the targeted discovery of antibodies that bind to our GlycoTargets, offering increased tumor-specificity compared to simple protein targets.”
    Poster details are as follows:

EchoNous Announces Revolutionary AI Enhancements in Upcoming Kosmos Release for Apple iOS

Retrieved on: 
Friday, April 5, 2024
Cardiac output, SHM, ACP, POCUS, AIUM, Abdomen, IOS, TDI, Torso, Doppler effect, Workflow, Heart, Cosmos, ACC, IPhone, Medical imaging

REDMOND, Wash., April 05, 2024 (GLOBE NEWSWIRE) -- EchoNous, a leading innovator in ultrasound technology, is thrilled to announce the upcoming Kosmos 2.2 release on Apple iOS, a monumental update enriched with powerful new automated enhancements and significant workflow improvements, setting a new standard in point-of-care (POCUS) imaging.

Key Points: 
  • REDMOND, Wash., April 05, 2024 (GLOBE NEWSWIRE) -- EchoNous, a leading innovator in ultrasound technology, is thrilled to announce the upcoming Kosmos 2.2 release on Apple iOS, a monumental update enriched with powerful new automated enhancements and significant workflow improvements, setting a new standard in point-of-care (POCUS) imaging.
  • This feature is especially beneficial for new users, ensuring that they operate under the preset that will give them optimal image clarity.
  • These AI-driven features exemplify EchoNous’ commitment to enhancing user control while streamlining procedures, allowing for uninterrupted scanning and optimal imaging results.
  • EchoNous is excited to showcase these groundbreaking features at ACC and forthcoming shows such as AIUM, ACP, SHM, and ASE in the weeks ahead.

HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations

Retrieved on: 
Thursday, April 4, 2024
Rexall, Patient, Pharmacist, Workflow, OTC, ID, Point-of-care testing, Pharmaceutical industry

The Companies have been working closely to develop the best patient approaches and internal workflows to ensure the most successful deployment of this powerful point-of-care testing platform.

Key Points: 
  • The Companies have been working closely to develop the best patient approaches and internal workflows to ensure the most successful deployment of this powerful point-of-care testing platform.
  • “To successfully screen and manage chronic and infectious disease, healthcare systems need pharmacists to play an active role,” said Hector Bremner, CEO of Avricore Health.
  • The next steps will be to deploy a minimum of another 20 locations spread out between stores in Alberta and Ontario.
  • After each deployment, the teams will collaborate to assess deployment workflow, refine processes and identify further deployment opportunities based on patient and pharmacist feedback.

Advanced Cybersecurity Platform Now Integrates Six Vulnerability Management Tools Into One Interactive Dashboard

Retrieved on: 
Thursday, April 4, 2024
Internet of things, Automation, Risk, Embedded, Workflow, OP, Risk management, Software, Original equipment manufacturer, Medical device

These new capabilities are now available through a private beta program that allows users to test the flagship vulnerability management tool for free using their own device firmware.

Key Points: 
  • These new capabilities are now available through a private beta program that allows users to test the flagship vulnerability management tool for free using their own device firmware.
  • “Our primary aim with this release is to simplify cybersecurity risk management for OEMs across the embedded systems and smart device landscape,” said Irby Thompson, CEO and co-founder, OP[4].
  • The platform distinguishes between exploitable and benign threats at the binary code level and provides detailed insights and informed risk scoring through an interactive security dashboard.
  • Executives from OP[4] will be at Embedded World April 9-11, 2024 to showcase the expanded product security platform.